Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Clinical trial NCT05082519 · RECRUITING

Trial details

NCT number: NCT05082519
Sponsor: Etan Orgel
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia Obesity

Start date: 2022-03-12
Primary completion: 2026-10-15
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.